Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanraksha Mayya

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|May 13, 2026
Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA TrialsRajeev Soman, Sanraksha Mayya, Geethu Joe
Medical Mycology Case Reports|November 10, 2025
VAPA strikes the patient again!Rajeev Soman, Sanraksha Mayya, Sushrut Ganpule, et al.
Medical Mycology Case Reports|October 13, 2025
Isavuconazole: Need for therapeutic drug monitoring and CYP polymorphism testingRajeev Soman, Sanraksha Mayya, Rahul Doshi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Microbial Drug Resistance (Larchmont, N.Y.)|May 13, 2026
Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA TrialsRajeev Soman, Sanraksha Mayya, Geethu Joe
Medical Mycology Case Reports|November 10, 2025
VAPA strikes the patient again!Rajeev Soman, Sanraksha Mayya, Sushrut Ganpule, et al.
Medical Mycology Case Reports|October 13, 2025
Isavuconazole: Need for therapeutic drug monitoring and CYP polymorphism testingRajeev Soman, Sanraksha Mayya, Rahul Doshi, et al.
Pageof 1